Skip to content

A Comparison of Tracheal Intubation Using the Totaltrack vs the Macintosh Laryngoscope in Obese Patients

A Comparison of Tracheal Intubation Using the Totaltrack vs the Macintosh Laryngoscope

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03106974
Acronym
Ovesion
Enrollment
1440
Registered
2017-04-11
Start date
2017-05-01
Completion date
2019-05-01
Last updated
2017-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Desaturation, Endotracheal Intubation, Obesity, Ventilation

Brief summary

Airway management in obese patients has to consider that mask ventilation (DMV) risk is increased and difficult tracheal intubation (DTI) risk may be increased too. In obese patients, is essential to prevent early arterial oxygen desaturation related to a reduced functional residual capacity (FRC), atelectasis formation during anesthetic induction and after tracheal intubation, because oxygenation maintenance is the cornerstone of the airway management of the obese patient. Endotracheal intubation is usually required to allow unrestricted surgical approach. The Macintosh laryngoscope is the standard method. However, sometimes this technique is ineffective and poorly tolerated by the obese patient. The Totaltrack™ (MedComflow S.A., Barcelona, Spain) is a hybrid device, between a supraglottic airway and a videolaryngoscope with an anatomically shaped blade. It allows fibreoptic visualization of the larynx for tracheal intubation and was developed to aid both ventilation and tracheal intubation, at the time of anticipated and unanticipated difficult airway management. However, despite its use in clinical practice, there are no comparative studies regarding direct laryngoscopy in obese patients.

Interventions

DEVICEorotracheal intubation Macintosh Laryngoscope

orotracheal intubation (OTI) after induction of anesthesia and complete relaxation

DEVICEorotracheal intubation Totaltrack VLM

orotracheal intubation (OTI) after induction of anesthesia and complete relaxation

Sponsors

AnestesiaR
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* BMI \> 30. * ASA 1-3 * Scheduled surgeries that require orotracheal intubation. * General anesthesia with neuromuscular relaxation before intubation. * Patients who sign informed consent.

Exclusion criteria

* ASA 4 * Difficult airway already known. * Alterations of airway documented, with previous tracheostomy or involve anatomical alterations. * General anesthesia that not require orotracheal intubation or neuromuscular relaxation. * Symptomatic gastro-esophageal reflux. * Lap-Band carrier. * Allergy medications to use. * Urgent surgery.

Design outcomes

Primary

MeasureTime frameDescription
saturation of blood oxygen at the end of orotracheal intubationTime of Orotracheal intubation (TOTI) (up to 1 hour)We will compare the blood oxygen saturation at the end of orotracheal intubation with macintosh and totaltrack. The end of successful tracheal intubation will be established to obtain a curve of Capnography.

Secondary

MeasureTime frameDescription
POGO ScoreTime of Orotracheal intubation (TOTI) (up to 1 hour)POGO Score
hemodynamic responseTOTI pre and postintubation (up to 10 minutes)hemodynamic response
Degree of satisfaction of the researchertime of postintubation (up to 10 minutes)Visual Analogic Scale (0-5)
Number of attempts of endotracheal intubationTime of Orotracheal intubation (TOTI) (up to 1 hour)Number of attempts of endotracheal intubation
IDS ScaleTime of Orotracheal intubation (TOTI) (up to 1 hour)IDS Scale
number of maneuversTime of Orotracheal intubation (TOTI) (up to 1 hour)number of maneuvers
adverse effects encountered during intubationTime of Orotracheal intubation (TOTI) (up to 1 hour)adverse effects encountered during intubation
ComplicationsTime Frame: TOTI and postintubation (up to 24 hours)Complications after intubation
Total time of successful intubationTime of Orotracheal intubation (TOTI) (up to 1 hour)Total time of successful intubation

Countries

Spain

Contacts

Primary ContactEugenio D. Martinez Hurtado, M.D.
OvesionTT@gmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026